We are a seed stage startup focusing on building an end-to-end complex illness management solution. We are seeking a CTO that has experience leading product building efforts in the digital health space who can serve as a thought leader in scaling treatment for complex illnesses (such as Long COVID, ME/CFS, POTS) through technology.
We need a CTO who: has a blend of technical and product experience, has experience building engineering teams, iterating on early stage products, leading technical and product efforts in a seed or series A startup. Above all, we are looking for a partner with an owner's mentality that will be essential for the realization of our product vision.
The perfect fit for this role is someone who is looking to make an impact on patients that have been suffering from difficult conditions without appropriate care. A candidate with lived personal experience caring for a patient or was/is a patient themselves is a plus!
We are open to having someone join the company full time or part-time and are open to candidates who prefer fully remote, hybrid, or in-person work.
Responsibilities:
-Lead design and development our core products which will allow our diagnostic and treatment offerings to serve every patient in the US
-Responsible for the technology architecture and technical leadership of the organization
-Make architecture decisions to ensure a strong, stable, and scalable product
-Build out our tech stack and engineering hiring plan
-Lead product roadmap efforts in partnership with leadership team
Benefits:
-Early-joiner equity
-Competitive salary
-Health Insurance
-401k matching
-Option for fully remote, hybrid, or in-person work
-Full time or part time
A little bit about us:
RTHM is backed by Y Combinator, Overwater Ventures, and Khosla Ventures. We have a team of over 20 employees, 14 full time, who work in a mix of fully remote, hybrid, and fully in-person. In addition to our clinical efforts in treating patients with complex illnesses, we have also built out our own diagnostic lab that will start commercializing exclusive laboratory tests in mid 2023.
Our founders:
Dr. Ryan Kellogg is a pioneer in personalized medicine leveraging multi-omics and wearables data from Stanford with lived experience in some of the conditions we treat.
Dr. Jennifer Curtin is a physician expert with lived experience in the conditions we treat and has years of experience managing the patients in our target markets - she is part of the expert clinician panel that writes the US clinical guidelines for ME/CFS.
Our vision:
We envision a world where complex illness care is broadly accessible and effective, enabled through advances in technology for measuring health in high resolution over time. That is why RTHM stands for Real Time Health Monitoring.
RTHM
